Cosmo脱发新药三期临床告捷;石药集团双靶点新药FDA临床批准;百奥赛图B7H3/PTK7双抗ADC获FDA批准

药财社
Dec 08, 2025

●药闻快报▲关注药财社聚焦医药界▲1Cosmo脱发新药三期临床告捷近日,Cosmo Pharmaceuticals宣布Clascoterone 5%外用溶液治疗男性雄激素性脱发(AGA)的两项III期临床试验取得积极结果。试验结果显示,Clascoterone 5%溶液在目标区域毛发计数方面达到了具有统计学意义(p<0.05)且临床意义重大的改善,其中一项研究更是实现了惊人的539%相对改善率。除...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10